Friday, June 13, 2025
HomeDr. Suhani Sinha

People

Quick Links

Notification Center

Dr. Suhani Sinha

Associate Professor

Department of Regulatory Toxicology

National Institute of Pharmaceutical Education & Research Hajipur,

Bihar India – 844 102

E-mail: suhani[dot]sinha[at]niperhajipur[dot]ac[dot]in;

Faculty CV

Academics

Study programme

Institute

Masters in pharmacy

BITS Pilani, Rajasthan 1998-2000

Ph.D. In Pharmaceutical Sciences

G.D. Goenka University, Gurugram

Research Areas
Novel Drug Delivery System, Precision Medicine and targeted therapeutics
Experience

  • Year Dec 2023 to Present: NIPER, Hajipur. 

Working as Associate Professor, Department of Regulatory Toxicology, NIPER Hajipur.

  • Year Nov 2021 to Dec 2023: M/s. Krishat Pharma Ind. Ltd., Ibadan, Nigeria. 

Worked as ‘Head- Manufacturing’.

  • Year Oct 2017 to Nov 2021: GD Goenka University, Gurugram.

Worked as Assistant Professor in the Department of Pharmacy, School of Medical and Allied Sciences.

  • Year Jan 2002 –Oct 2017: M/s. Ranbaxy Laboratories Limited, Gurgaon (Now M/s. Sun Pharmaceutical Industries Limited):

Worked as senior scientist in Product Development and Research Department to develop products in R&D and further scale up to exhibit stage for ANDA filings for US, Europe, India, and Emerging markets.

  • Year Jan 2001- Jan 2002: M/s. Torrent Research Centre, Bhat:

Worked as scientist in formulation development department.

  • Year Jan2000 –Jul2000: M/s. Ohm Laboratories, New Jersey USA:

Worked as research associate in product development department.

Distinctions

Patents published:

  1. Water dispersible tablets of Lamotrigine. (International publication date: 02 December 2004; International Publication WO 2004/103340 A1)
  2. Stable Lamotrigine pharmaceutical compositions and process for their preparation. (International publication date: 30 September 2004; International Publication WO 2004/082587 A3)
  3. Stable Dapagliflozin preparations. (International publication date: 03 September 2015; International Publication WO 2015/128853 A1)
  4. Dapagliflozin co-crystal formulations (International publication date: 07 December 2017; International Publication WO 2017/208136 A1)
  5. Sustained release composition of dimethyl fumarate 202311012541A
  6. Biocompatible nanoparticles of tizanidine hydrochloride in orodispersible films 202311010803A
  7. Empagliflozin containing chitosan-alginate nanoparticles in orodispersible film. 202311009974 A.

Certifications:

  1. Lifetime member of ‘Association of Pharmaceutical Teachers of India (APTI)’.
  2. ‘Black Belt- Lean Six Sigma’ certified by Var Sigma Exemplar Global (Internationally recognized).
  3. Global certificate in Data Science awarded by INSAID.
  4. Disseminated webinars and lectures on topics like ‘Pharmacovigilance programme of India’ and ‘Role of Intellectual property rights from innovation to start-ups, ‘Good Clinical Practices’.

Research Publications

  1. Research Article: Chitosan-alginate core-shell-corona shaped nanoparticles of dimethyl fumarate in orodispersible film to improve bioavailability in treatment of multiple sclerosis: Preparation, characterization and biodistribution in rats, Journal of Drug Delivery Science and Technology, 64(2021), https://doi.org/10.1016/j.jddst.2021.102645. (IF:5.062)
  2. Research Article: Development of biocompatible nanoparticles of tizanidine hydrochloride in orodispersible films: In vitro characterization, ex vivo permeation and cytotoxic study on carcinoma Current Drug Deliv. 2022 Mar 21. Doi: 10.2174/1567201819666220321111338. Epub. PMID: 35319369. (IF: 3.758)
  3. Research Article: Empagliflozin containing chitosan-alginate nanoparticles in orodispersible film: preparation, characterization,         pharmacokinetic evaluation, and its in-vitro anticancer Drug Dev Ind Pharm. 2022 Aug 1:1-41. Doi: 10.1080/03639045.2022.2108829. Epub ahead of print. PMID: 35913103. (IF: 3.727)
  4. Review Article: Effects and safety profile of commonly used Herbal anti-diabetic (IF:1.858) DOI url: https://doi.org/10.30574/gscbps.2018.4.2.0067 (IF:
  5. Review Article: Precision medicine as a promising tool to empower research in healthcare industry. DOI url: https://doi.org/10.30574/gscbps.2018.4.3.0068 (IF: 858)
  6. Review Article: Enabling Process Improvement and Problem Solving in Pharmaceutical Industry through Six Sigma (Asian Journal of Biochemical and Pharmaceutical Sciences, Special Issue, pg- 74-85) (UGC Journal)
  7. Review Article: Quality by design in Pharmaceutical Product (Acta Scientific Pharmaceutical Sciences (ISSN:2581-5423, Vol. 3, Issue January 2019) (IF:1.403)
  8. Review Article: Oral Soluble Films: Attributes of the Polymeric Material and Critical Process Parameters for Designing Good Quality DOI: 10.2174/2452271603666191210121944 (IF: 3.057)
  9. Review Article: Nanoparticles loaded in consumable polymeric oral films: A smart dosage form design for oral DOI url: https://doi.org/10.30574/gscbps.2020.12.1.0153 (IF:1.858)
  10. Review Article: Safety, efficacy, and quality profile of Ayurvedic anti-cancer DOI url:  https://doi.org/10.30574/gscbps.2020.12.1.0152 (IF:1.858)
  11. Review Article: Mindfulness Regarding the Health Benefits of Basil (Tulsi) Leaves https://doi.org/10.32628/IJSRST218419
  12. Review Article: A Review of Biologic anti- cancer DOI url: https://doi.org/10.30574/gscbps.2020.12.1.0151 (IF:1.858)
  13. Molecular insights into diabetic wound healing: Focus on Wnt/β-catenin and MAPK/ERK signaling pathways. Cytokine, Volume 191, July 2025, 156957